Observational studyBMC health services research2022
Costs associated with adverse events from remission induction for children with Acute Lymphoblastic Leukemia (ALL).
Eréndira Mejía-Aranguré et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it